The co-administration of anlotinib with other medications must be strictly conducted under the guidance of a physician. As an anti-tumor targeted drug, its interactions with other drugs may affect therapeutic efficacy or increase the risk of adverse reactions. The decision to co-administer anlotinib requires a comprehensive assessment based on the patient’s individual condition, treatment regimen, and the pharmacological properties of the drugs involved. Patients are not allowed to adjust the dosage or co-administer other drugs without authorization.
Key Drug Interactions to Note
1. Drugs Interacting with the CYP3A4 Enzyme System
Anlotinib is primarily metabolized via the CYP3A4 enzyme pathway. Co-administration with potent CYP3A4 inhibitors (e.g., ketoconazole) or inducers (e.g., rifampicin) may significantly elevate or reduce anlotinib plasma concentrations, necessitating dosage adjustments or avoidance of co-administration.
Certain antifungal agents, antibiotics, and antiepileptic drugs may interfere with this metabolic pathway. Patients must proactively inform their physicians of all medications they are taking.
2. Anticoagulant/Antiplatelet Drugs
Co-administration with anticoagulants (e.g., warfarin) or antiplatelet agents (e.g., aspirin) may increase bleeding risk. Close monitoring of coagulation function is required, especially in postoperative patients or those with a bleeding tendency.
3. Other Anticancer Drugs
Combination therapy with chemotherapeutic agents or other targeted drugs may exacerbate adverse effects such as myelosuppression and hypertension. Physicians must evaluate patient tolerance and adjust dosages accordingly.
Common Scenarios Requiring Caution for Co-administration
1. Over-the-Counter (OTC) Drugs and Traditional Chinese Medicines (TCMs)
Some non-prescription analgesics and antipyretics (e.g., ibuprofen) and TCM preparations may increase hepatic and renal burden or interfere with drug metabolism. Patients should consult their physicians before using such products.
2. Chronic Disease Medications
For patients taking drugs for hypertension or diabetes, close monitoring of blood pressure and blood glucose levels is essential. Dosage adjustments of antihypertensive medications may be required to manage anlotinib-induced hypertension.
Medication Principles and Medical Consultation Guidelines
1. Strict Adherence to Physician Instructions
Provide a complete medication history (including health supplements) before initiating treatment.
Undergo regular monitoring of hepatic/renal function and blood routine tests during treatment. Seek immediate medical attention if any abnormalities occur.
2. Special Populations
Patients with hepatic or renal insufficiency and elderly patients require individualized dosage adjustments.
Anlotinib is contraindicated during pregnancy and lactation.
Anlotinib is a prescription-only medication. All co-administration regimens must be formulated by oncologists based on the patient’s condition, diagnostic test results, and drug interaction data. Patients must not increase or decrease drug dosages arbitrarily or rely on non-professional advice.
